UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

Annals of oncology, 2013-04, Vol.24 (4), p.1067-1073

2013

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled, phase III trial of erlotinib with or without a c-Met inhibitor tivantinib (ARQ 197) in Asian patients with previously treated stage IIIB/IV nonsquamous nonsmall-cell lung cancer harboring wild-type epidermal growth factor receptor (ATTENTION study)

Annals of oncology, 2015-10, Vol.26 (10), p.2066-2072

2015

Volltextzugriff (PDF)

Randomized phase III and extension studies: efficacy and impacts on quality of life of naldemedine in subjects with opioid-induced constipation and cancer

Annals of oncology, 2018-06, Vol.29 (6), p.1461-1467

2018

Volltextzugriff (PDF)

Quantitative Analysis of Conebeam CT for Delineating Stents in Stent-Assisted Coil Embolization

American journal of neuroradiology : AJNR, 2018-03, Vol.39 (3), p.488-493

2018

Volltextzugriff (PDF)

A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial

Annals of oncology, 2015-07, Vol.26 (7), p.1401-1408

2015

Volltextzugriff (PDF)

A phase II trial of dose-dense chemotherapy, followed by surgical resection and or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9606)

British journal of cancer, 2010-06, Vol.103 (1), p.6-11

2010

Volltextzugriff (PDF)

Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403)

British journal of cancer, 2008-03, Vol.98 (5), p.907-914

2008

Volltextzugriff (PDF)

A randomised, placebo-controlled, double-blind study of aprepitant in nondrinking women younger than 70 years receiving moderately emetogenic chemotherapy

British journal of cancer, 2013-08, Vol.109 (4), p.859-865

2013

Volltextzugriff (PDF)

A randomized, open-label, multicenter, phase 3 study to compare the efficacy and safety of eribulin to treatment of physician’s choice in patients with advanced non-small cell lung cancer

Annals of oncology, 2017-09, Vol.28 (9), p.2241-2247

2017

Volltextzugriff (PDF)

Docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte-colony stimulating factor for pretreated non-small cell lung cancer

Annals of oncology, 2018-10, Vol.29, p.viii505-viii505

2018

Volltextzugriff (PDF)

Afatinib (AFA) plus bevacizumab (BEV) combination after osimertinib (OSIME) failure for aDvanced EGFR-mutant non-small cell lung cancer (NSCLC): A multicenter prospective single arm phase II study (ABCD-study)

Annals of oncology, 2018-10, Vol.29, p.viii543-viii544

2018

Volltextzugriff (PDF)

A randomized, open-label, phase III trial comparing amrubicin versus docetaxel in patients with previously treated non-small-cell lung cancer

Annals of oncology, 2017-02, Vol.28 (2), p.285-291

2017

Volltextzugriff (PDF)

Preference in time of insulin injection in type 2 diabetic patients treated with once-daily long-acting insulin analog

Diabetes, obesity & metabolism, 2016-11, Vol.18 (11), p.1098-1099

2016

Volltextzugriff (PDF)

Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer

British journal of cancer, 2003-02, Vol.88 (3), p.335-341

2003

Volltextzugriff (PDF)

Metformin or gliclazide, rather than glibenclamide, attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes

Diabetologia, 2004-11, Vol.47 (11), p.1906-1913

2004

Volltextzugriff (PDF)

Efficacy and Safety of Eribulin Compared with Treatment of Physician’s Choice (TPC) in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC): Results from a Phase 3 Study

International journal of radiation oncology, biology, physics, 2014-12, Vol.90 (5), p.1266-1266

2014

Volltextzugriff (PDF)

Stereotactic Body Radiation Therapy as a Part of Definitive Treatment for Synchronous Double Primary Lung Cancer

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S606-S606

2014

Volltextzugriff (PDF)

Aldose reductase C-106T gene polymorphism is associated with diabetic retinopathy in Japanese patients with type 2 diabetes

Diabetes research and clinical practice, 2011-06, Vol.92 (3), p.e57-e60

2011

Volltextzugriff (PDF)

A candidate gene approach to genetic contributors to the development of IgA nephropathy

Nephrology, dialysis, transplantation, 2012-03, Vol.27 (3), p.1020-1030

2012

Volltextzugriff (PDF)

3079 Randomized phase II trial of amrubicin plus irinotecan versus cisplatin plus irinotecan in chemo-naïve patients with extensivedisease small-cell lung cancer: Results of the Japan Multinational Trial Organization (JMTO) LC 08-01

European journal of cancer (1990), 2015-09, Vol.51, p.S623-S624

2015

Volltextzugriff (PDF)

A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapy

Annals of oncology, 2009-11, Vol.20 (11), p.1860-1866

2009

Volltextzugriff (PDF)

Amrubicin (Amr) Versus Docetaxel (Dtx) As Second- or Third-Line Treatment for Non-Small Cell Lung Cancer (Nsclc): a Randomized Phase III Trial

Annals of oncology, 2014-09, Vol.25, p.iv432

2014

Volltextzugriff (PDF)

The Phosphodiesterase Inhibitor Cilostazol Induces Regression of Carotid Atherosclerosis in Subjects With Type 2 Diabetes Mellitus Principal Results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) Study: A Randomized Trial

Journal of vascular surgery, 2010-11, Vol.52 (5), p.1421-1422

2010

Volltextzugriff (PDF)

Feasibility of Definitive Concurrent Chemoradiation Therapy for Patients Over 80 Years Old With Non-small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S587-S587

2012

Volltextzugriff (PDF)

Combined effect of oxidative stress-related gene polymorphisms on atherosclerosis

Biochemical and biophysical research communications, 2009-02, Vol.379 (4), p.861-865

2009

Volltextzugriff (PDF)

1 – 25 von 248

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(201)
Mit Volltextzugriff
(208)

Publikationsform

Artikel
(238)
Tagungsberichte
(10)

Sprache

Englisch
(214)
Japanisch
(37)

Erscheinungsjahr

n.n

Thema

Humans
(94)
Science & Technology
(89)
Male
(84)
Life Sciences & Biomedicine
(78)
Female
(71)
Middle Aged
(59)
Adult
(52)
Aged
(50)
Biological And Medical Sciences
(38)
Medical Sciences
(32)
Animals
(25)
Oncology
(25)
Endocrinology & Metabolism
(24)
Lung Neoplasms - Drug Therapy
(21)
Rats
(19)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(17)
Lung Neoplasms - Pathology
(16)
Rats, Inbred Strains
(15)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(14)
Treatment Outcome
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

A randomized, double-blind, placebo-controlled, phase III trial of erlotinib with or without a c-Met inhibitor tivantinib (ARQ 197) in Asian patients with previously treated stage IIIB/IV nonsquamous nonsmall-cell lung cancer harboring wild-type epidermal growth factor receptor (ATTENTION study)

Randomized phase III and extension studies: efficacy and impacts on quality of life of naldemedine in subjects with opioid-induced constipation and cancer

Quantitative Analysis of Conebeam CT for Delineating Stents in Stent-Assisted Coil Embolization

A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial

A phase II trial of dose-dense chemotherapy, followed by surgical resection and or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9606)

Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403)

A randomised, placebo-controlled, double-blind study of aprepitant in nondrinking women younger than 70 years receiving moderately emetogenic chemotherapy

A randomized, open-label, multicenter, phase 3 study to compare the efficacy and safety of eribulin to treatment of physician’s choice in patients with advanced non-small cell lung cancer

Docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte-colony stimulating factor for pretreated non-small cell lung cancer

Afatinib (AFA) plus bevacizumab (BEV) combination after osimertinib (OSIME) failure for aDvanced EGFR-mutant non-small cell lung cancer (NSCLC): A multicenter prospective single arm phase II study (ABCD-study)

A randomized, open-label, phase III trial comparing amrubicin versus docetaxel in patients with previously treated non-small-cell lung cancer

Preference in time of insulin injection in type 2 diabetic patients treated with once-daily long-acting insulin analog

Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer

Metformin or gliclazide, rather than glibenclamide, attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes

Efficacy and Safety of Eribulin Compared with Treatment of Physician’s Choice (TPC) in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC): Results from a Phase 3 Study

Stereotactic Body Radiation Therapy as a Part of Definitive Treatment for Synchronous Double Primary Lung Cancer

Aldose reductase C-106T gene polymorphism is associated with diabetic retinopathy in Japanese patients with type 2 diabetes

A candidate gene approach to genetic contributors to the development of IgA nephropathy

3079 Randomized phase II trial of amrubicin plus irinotecan versus cisplatin plus irinotecan in chemo-naïve patients with extensivedisease small-cell lung cancer: Results of the Japan Multinational Trial Organization (JMTO) LC 08-01

A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapy

Amrubicin (Amr) Versus Docetaxel (Dtx) As Second- or Third-Line Treatment for Non-Small Cell Lung Cancer (Nsclc): a Randomized Phase III Trial

The Phosphodiesterase Inhibitor Cilostazol Induces Regression of Carotid Atherosclerosis in Subjects With Type 2 Diabetes Mellitus Principal Results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) Study: A Randomized Trial

Feasibility of Definitive Concurrent Chemoradiation Therapy for Patients Over 80 Years Old With Non-small Cell Lung Cancer

Combined effect of oxidative stress-related gene polymorphisms on atherosclerosis

Suchergebnisse filtern